HER2: a never ending story

被引：19

作者：

Dieci, Maria Vittoria ^{[1
,2
]}

Miglietta, Federica ^{[1
,2
]}

机构：

[1] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35128 Padua, Italy

[2] Ist Oncol Veneto IOV IRCCS, Med Oncol 2, Padua, Italy

来源：

LANCET ONCOLOGY | 2021年 / 22卷 / 08期

关键词：

D O I：

10.1016/S1470-2045(21)00349-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1051 / 1052

页数：2

共 10 条

[1] Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study [J].

Banerji, Udai ;

van Herpen, Carla M. L. ;

Saura, Cristina ;

Thistiethwaite, Fiona ;

Lord, Simon ;

Moreno, Victor ;

Macpherson, Iain R. ;

Boni, Valentina ;

Rolfo, Christian ;

de Vries, Elisabeth G. E. ;

Rottey, Sylvie ;

Geenen, Jilt ;

Eskens, Ferry ;

Gil-Martin, Marta ;

Mommers, Ellen C. ;

Koper, Norbert P. ;

Aftimos, Philippe .

LANCET ONCOLOGY, 2019, 20 (08) :1124-1135

[2] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer [J].

Bardia, A. ;

Hurvitz, S. A. ;

Tolaney, S. M. ;

Loirat, D. ;

Punie, K. ;

Oliveira, M. ;

Brufsky, A. ;

Sardesai, S. D. ;

Kalinsky, K. ;

Zelnak, A. B. ;

Weaver, R. ;

Traina, T. ;

Dalenc, F. ;

Aftimos, P. ;

Lynce, F. ;

Diab, S. ;

Cortes, J. ;

O'Shaughnessy, J. ;

Dieras, V ;

Ferrario, C. ;

Schmid, P. ;

Carey, L. A. ;

Gianni, L. ;

Piccart, M. J. ;

Loibl, S. ;

Goldenberg, D. M. ;

Hong, Q. ;

Olivo, M. S. ;

Itri, L. M. ;

Rugo, H. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) :1529-1541

[3] Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials [J].

Denkert, Carsten ;

Seither, Fenja ;

Schneeweiss, Andreas ;

Link, Theresa ;

Blohmer, Jens-Uwe ;

Just, Marianne ;

Wimberger, Pauline ;

Forberger, Almuth ;

Tesch, Hans ;

Jackisch, Christian ;

Schmatloch, Sabine ;

Reinisch, Mattea ;

Solomayer, Erich F. ;

Schmitt, Wolfgang D. ;

Hanusch, Claus ;

Fasching, Peter A. ;

Luebbe, Kristina ;

Solbach, Christine ;

Huober, Jens ;

Rhiem, Kerstin ;

Marme, Frederik ;

Reimer, Toralf ;

Schmidt, Marcus ;

Sinn, Bruno, V ;

Janni, Wolfgang ;

Stickeler, Elmar ;

Michel, Laura ;

Stoetzer, Oliver ;

Hahnen, Eric ;

Furlanetto, Jenny ;

Seiler, Sabine ;

Nekljudova, Valentina ;

Untch, Michael ;

Loibl, Sibylle .

LANCET ONCOLOGY, 2021, 22 (08) :1151-1161

[4] Unlocking the potential of antibody-drug conjugates for cancer therapy [J].

Drago, Joshua Z. ;

Modi, Shanu ;

Chandarlapaty, Sarat .

NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (06) :327-344

[5]

Gampenrieder S, 2019, SAN ANTONIO BREAST C

[6] HER2-low breast cancer: Evolution from primary breast cancer to relapse [J].

Miglietta, F. ;

Griguolo, G. ;

Bottosso, M. ;

Giarratano, T. ;

Lo Mele, M. ;

Fassan, M. ;

Cacciatore, M. ;

Genovesi, E. ;

De Bartolo, D. ;

Vernaci, G. ;

Conte, P. F. ;

Guarneri, V. ;

Dieci, M. V. .

ANNALS OF ONCOLOGY, 2021, 32 :S23-S23

[7] Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study [J].

Modi, Shanu ;

Park, Haeseong ;

Murthy, Rashmi K. ;

Iwata, Hiroji ;

Tamura, Kenji ;

Tsurutani, Junji ;

Moreno-Aspitia, Alvaro ;

Doi, Toshihiko ;

Sagara, Yasuaki ;

Redfern, Charles ;

Krop, Ian E. ;

Lee, Caleb ;

Fujisaki, Yoshihiko ;

Sugihara, Masahiro ;

Zhang, Lin ;

Shahidi, Javad ;

Takahashi, Shunji .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) :1887-+

[8] Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy [J].

Rosenberg, Jonathan E. ;

O'Donnell, Peter H. ;

Balar, Arjun, V ;

McGregor, Bradley A. ;

Heath, Elisabeth, I ;

Yu, Evan Y. ;

Galsky, Matthew D. ;

Hahn, Noah M. ;

Gartner, Elaina M. ;

Pinelli, Juan M. ;

Liang, Shang-Ying ;

Melhem-Bertrandt, Amal ;

Petrylak, Daniel P. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (29) :2592-+

[9] Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer [J].

Schettini, Francesco ;

Chic, Nuria ;

Braso-Maristany, Fara ;

Pare, Laia ;

Pascual, Tomas ;

Conte, Benedetta ;

Martinez-Saez, Olga ;

Adamo, Barbara ;

Vidal, Maria ;

Barnadas, Esther ;

Fernandez-Martinez, Aranzazu ;

Gonzalez-Farre, Blanca ;

Sanfeliu, Esther ;

Cejalvo, Juan Miguel ;

Perrone, Giuseppe ;

Sabarese, Giovanna ;

Zalfa, Francesca ;

Peg, Vicente ;

Fasani, Roberta ;

Villagrasa, Patricia ;

Gavila, Joaquin ;

Barrios, Carlos H. ;

Lluch, Ana ;

Martin, Miguel ;

Locci, Mariavittoria ;

De Placido, Sabino ;

Prat, Aleix .

NPJ BREAST CANCER, 2021, 7 (01)

[10] HER2-Low Breast Cancer: Pathological and Clinical Landscape [J].

Tarantino, Paolo ;

Hamilton, Erika ;

Tolaney, Sara M. ;

Cortes, Javier ;

Morganti, Stefania ;

Ferraro, Emanuela ;

Marra, Antonio ;

Viale, Giulia ;

Trapani, Dario ;

Cardoso, Fatima ;

Penault-Llorca, Frederique ;

Viale, Giuseppe ;

Andre, Fabrice ;

Curigliano, Giuseppe .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (17) :1951-+

← 1 →